Samuel Klein, MD, and Blandine Laferrère, MD, PhD, presented different viewpoints on whether the metabolic benefits of Roux-en-Y gastric bypass surgery are due to weight loss alone.

Maria S. Remedi, PhD, Richard O’Brien, PhD, Aleksey Matveyenko, PhD, and Jennifer Bruin, PhD, explained several ways that diet and environmental factors can affect beta cell function, metabolic disease, and diabetes during the Scientific Sessions.

Four researchers—Emily J. Gallagher, MD, PhD, MRCPI, M. Celeste Simon, PhD, Lydia Finley, PhD, and Marcus Goncalves, MD, MSE, PhD—looked at the connections between insulin and cancer during the Scientific Sessions.

Experts in four rare forms of diabetes discussed strategies for diagnosing and treating patients with these atypical conditions during the Scientific Sessions. The session featured Janet B. McGill, MD, Marina Basina, MD, Armen Yerevanian, MD, and Mark S. Anderson, MD, PhD.

“Stress is epidemic in the U.S. and other Western [countries], and most of our stressors are social,” said Carol A. Shively, PhD, in a session on the influence of social stress and social inequalities on metabolic health. She presented evidence based on animal models. Mika Kivimäki, PhD, FMedSci, presented evidence of the correlation between socioeconomic…

“The road ahead for the treatment of type 2 diabetes is fresh,” said Alice Y.Y. Cheng, MD. “The future, in terms of what we will be able to offer our patients to help them meet their metabolic goals, appears to be very positive.”

Kristen J. Nadeau, MD, MS, outlined the unique cardiometabolic mechanisms and consequences of youth-onset type 1 and type 2 diabetes in her award lecture.

An international panel of diabetes prevention researchers including Mike Sampson, MD, Kerri Lynn Knippen, PhD, MPH, RDN, LD, BC-ADM, Pilvikki Absetz, PhD, and Anne M. Wolf, MS, RDN, shared lessons learned from the implementation of type 2 diabetes prevention programs around the world during a symposium Monday.

As an early-career scientist, Nicholas J. Wareham, FMedSci, FRCP, FFPHM, MBBS, MSc, PhD, developed a strong interest in diabetes screening and was fascinated by then-emerging details of the links between risk factors and type 2 diabetes.

David G. Marrero, PhD, advocated for a social-ecological model to better understand and integrate diabetes care in a symposium focused on preserving mental health across the lifespan of living with this disease.